sentences:  On the 4th September 2017, an application was submitted to the EMEA (European Medicines Agency) asking for an extension of marketing authorisation for Tepoxalin.The EMEA (European Medicines Agency) critiqued on the quality, safety and efficacy data submitted and the application was declined.Tepoxalin (C20H20ClN3O3) is produced by the condensation of a carboxyl group of 3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl] propanoic acid and an amino group of N-methylhydroxylamine.